Compare NEXN & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEXN | TOI |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.2M | 327.6M |
| IPO Year | 2021 | N/A |
| Metric | NEXN | TOI |
|---|---|---|
| Price | $5.66 | $2.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $12.00 | $6.00 |
| AVG Volume (30 Days) | 357.9K | ★ 2.3M |
| Earning Date | 03-04-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 237.45 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | $376,353,000.00 | ★ $461,039,000.00 |
| Revenue This Year | $5.43 | $28.51 |
| Revenue Next Year | N/A | $25.30 |
| P/E Ratio | $10.00 | ★ N/A |
| Revenue Growth | 7.80 | ★ 21.67 |
| 52 Week Low | $5.72 | $0.60 |
| 52 Week High | $12.60 | $4.88 |
| Indicator | NEXN | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 34.27 | 32.91 |
| Support Level | $5.81 | $3.30 |
| Resistance Level | $6.39 | $3.23 |
| Average True Range (ATR) | 0.28 | 0.23 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 8.33 | 19.74 |
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and advanced TV that helps empower advertisers, agencies, digital publishers and broadcasters to achieve desired outcomes, including increased efficiency and returns, across the media supply chain. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. Company operates in America, APAC, EMEA, regions, with majority revenue from America.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.